NEW YORK, April 26 – Syrrx has appointed Norman Halleen to the position of vice president of finance and chief financial officer, a new position, the company said Thursday.
Halleen comes to the company from Aradigm, a maker of drug delivery systems, where he served as CFO and vice president of finance.
Syrrx needed a CFO, said Nathaniel David, the company’s director of business development, because the company should be in a position to “examine other sources of financing,” including preparing for an initial public offering.
While David said the company has no immediate plans for an IPO, he added that hiring a CFO was important for a company of Syrrx’s size—meaning the number of employees and amount of money the company has to spend.
“It makes sense to prepare ourselves for more complex [financial] transactions,” David said.Halleen will be responsible for finance, facilities, and investor relations for the company.